Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Teva UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, United Kingdom
Exorex Lotion 5% v/w Cutaneous Emulsion.
| Pharmaceutical Form |
|---|
|
Cutaneous emulsion. A smooth mustard coloured emulsion. |
The active ingredient is coal tar solution 5% v/w.
Excipients with known effect:
Methyl hydroxybenzoate (E218) 0.10% w/w
Propyl hydroxybenzoate (E216) 0.05% w/w
Hydrogenated polyoxyl castor oil 0.45% w/w
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Coal tar |
Coal tar is an antipruritic and keratoplastic. It is used in eczema, psoriasis and other skin conditions. Tar acids have also been shown to have disinfectant properties. Coal tar may be used alone, or as part of a more extensive treatment regimen. |
| List of Excipients |
|---|
|
Polysorbate 80 |
High density polyethylene bottle containing titanium dioxide.
Polypropylene green flip-top caps.
Pack sizes: 100 and 250ml.
A professional sales pack of 30ml is also available.
Not all pack sizes may be marketed.
Teva UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG, United Kingdom
PL 00289/2306
3 November 1999/23 May 2007
| Drug | Countries | |
|---|---|---|
| EXOREX | Spain, Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
